Literature DB >> 15810620

Expression of Cdx2 in early GRCL of Barrett's esophagus induced in rats by duodenal reflux.

Takeshi Tatsuta1, Ken-Ichi Mukaisho, Hiroyuki Sugihara, Koichi Miwa, Tohru Tani, Takanori Hattori.   

Abstract

The intestine-specific caudal-related homeobox transcription factor Cdx2 is widely accepted to play a key role in intestinal development and differentiation in mammals. We studied the role of Cdx2 in the development of Barrett's esophagus (BE). In previous studies, we have shown a sequence of morphological changes of squamous epithelium leading to BE, found a peculiar metaplastic change common to other parts of gut, and proposed the concept of a "gut regenerative cell lineage" (GRCL). The GRCL is characterized by pyloric-foveolar metaplasia with goblet cell metaplasia, which occurs in the regenerative process in response to chronic inflammation. BE very likely develops through the GRCL, and we studied the expression of Cdx2 in various lesions of rat esophageal mucosa induced by duodenal reflux, using reverse transciptase-polymerase chain reaction and immunohistochemistry against Cdx2. We found that Cdx2 was expressed not only in specialized columnar epithelium (SCE) of BE, but also in several pyloric gland and foveolar metaplastic cells which developed in the basal layer of the squamous epithelium at an earlier stage of SCE development. These findings indicate that Cdx2 plays a crucial role in directing intestinal-type differentiation of the GRCL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15810620     DOI: 10.1007/s10620-005-2452-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  A faithful method for PCR-mediated global mRNA amplification and its integration into microarray analysis on laser-captured cells.

Authors:  Kazuhiko Aoyagi; Takeshi Tatsuta; Michiko Nishigaki; Shingo Akimoto; Chikako Tanabe; Yoko Omoto; Shin ichi Hayashi; Hiromi Sakamoto; Michiie Sakamoto; Teruhiko Yoshida; Masaaki Terada; Hiroki Sasaki
Journal:  Biochem Biophys Res Commun       Date:  2003-01-24       Impact factor: 3.575

2.  CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia.

Authors:  Takao Hinoi; Peter C Lucas; Rork Kuick; Samir Hanash; Kathleen R Cho; Eric R Fearon
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

3.  Colonic hamartoma development by anomalous duplication in Cdx2 knockout mice.

Authors:  Y Tamai; R Nakajima; T Ishikawa; K Takaku; M F Seldin; M M Taketo
Journal:  Cancer Res       Date:  1999-06-15       Impact factor: 12.701

4.  Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice.

Authors:  Debra G Silberg; Jessica Sullivan; Eugene Kang; Gary P Swain; Jennifer Moffett; Newman J Sund; Sara D Sackett; Klaus H Kaestner
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

5.  Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease.

Authors:  C Winters; T J Spurling; S J Chobanian; D J Curtis; R L Esposito; J F Hacker; D A Johnson; D F Cruess; J D Cotelingam; M S Gurney
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

6.  Adenocarcinoma of the esophagogastric junction and Barrett's esophagus.

Authors:  A J Cameron; C T Lomboy; M Pera; H A Carpenter
Journal:  Gastroenterology       Date:  1995-11       Impact factor: 22.682

7.  Gastric carcinogenesis by duodenal reflux through gut regenerative cell lineage.

Authors:  Ken-Ichi Mukaisho; Koichi Miwa; Hitomi Kumagai; Masamichi Bamba; Hiroyuki Sugihara; Takanori Hattori
Journal:  Dig Dis Sci       Date:  2003-11       Impact factor: 3.199

8.  Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa.

Authors:  Akashi Eda; Hiroyuki Osawa; Kiichi Satoh; Ichiro Yanaka; Ken Kihira; Yumiko Ishino; Hiroyuki Mutoh; Kentaro Sugano
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

9.  Gradient expression of Cdx along the rat intestine throughout postnatal development.

Authors:  J N Freund; R Boukamel; A Benazzouz
Journal:  FEBS Lett       Date:  1992-12-14       Impact factor: 4.124

10.  Implication of duodenogastric reflux in the pathogenesis of Barrett's oesophagus.

Authors:  P Gillen; P Keeling; P J Byrne; M Healy; R R O'Moore; T P Hennessy
Journal:  Br J Surg       Date:  1988-06       Impact factor: 6.939

View more
  27 in total

1.  Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia.

Authors:  Michael Quante; Govind Bhagat; Julian A Abrams; Frederic Marache; Pamela Good; Michele D Lee; Yoomi Lee; Richard Friedman; Samuel Asfaha; Zinaida Dubeykovskaya; Umar Mahmood; Jose-Luiz Figueiredo; Jan Kitajewski; Carrie Shawber; Charles J Lightdale; Anil K Rustgi; Timothy C Wang
Journal:  Cancer Cell       Date:  2012-01-17       Impact factor: 31.743

Review 2.  The role of acid and bile reflux in oesophagitis and Barrett's metaplasia.

Authors:  Rhonda F Souza
Journal:  Biochem Soc Trans       Date:  2010-04       Impact factor: 5.407

3.  Barrett's esophagus and animal models.

Authors:  Ryan A Macke; Katie S Nason; Ken-ichi Mukaisho; Takanori Hattori; Takashi Fujimura; Shozo Sasaki; Katsunobu Oyama; Tomoharu Miyashita; Tetsuo Ohta; Koichi Miwa; Michael K Gibson; Ali Zaidi; Usha Malhotra; Ajlan Atasoy; Tyler Foxwell; Blair Jobe
Journal:  Ann N Y Acad Sci       Date:  2011-09       Impact factor: 5.691

Review 4.  Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.

Authors:  Douglas B Stairs; Jianping Kong; John P Lynch
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

Review 5.  Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists.

Authors:  Bita V Naini; Rhonda F Souza; Robert D Odze
Journal:  Am J Surg Pathol       Date:  2016-05       Impact factor: 6.394

6.  [Barrett's esophagus: analyses from human and experimental animal studies].

Authors:  R Kushima; K-I Mukaisho; S Takemura; H Sugihara; T Hattori; M Vieth
Journal:  Pathologe       Date:  2013-03       Impact factor: 1.011

Review 7.  From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma.

Authors:  Ravindran Caspa Gokulan; Monica T Garcia-Buitrago; Alexander I Zaika
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

8.  Goblet Cell Ratio in Combination with Differentiation and Stem Cell Markers in Barrett Esophagus Allow Distinction of Patients with and without Esophageal Adenocarcinoma.

Authors:  Raphael Schellnegger; Anne Quante; Susanne Rospleszcz; Martina Schernhammer; Bettina Höhl; Moritz Tobiasch; Agnieszka Pastula; Anna Brandtner; Julian A Abrams; Konstantin Strauch; Roland M Schmid; Michael Vieth; Timothy C Wang; Michael Quante
Journal:  Cancer Prev Res (Phila)       Date:  2016-11-02

9.  Aspirin prevents NF-κB activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus.

Authors:  Xiaofang Huo; Xi Zhang; Chunhua Yu; Edaire Cheng; Qiuyang Zhang; Kerry B Dunbar; Thai H Pham; John P Lynch; David H Wang; Robert S Bresalier; Stuart J Spechler; Rhonda F Souza
Journal:  Gut       Date:  2017-04-25       Impact factor: 23.059

Review 10.  Barrett esophagus: what a mouse model can teach us about human disease.

Authors:  Michael Quante; Julian A Abrams; Yoomi Lee; Timothy C Wang
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.